Dr. Martens plc (FRA:3U2)

Dr. Martens Statistics

Total Valuation

Dr. Martens has a market cap or net worth of EUR 847.06 million. The enterprise value is 1.19 billion.

Market Cap	847.06M
Enterprise Value	1.19B

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	Aug 28, 2025

Share Statistics

Current Share Class	967.06M
Shares Outstanding	n/a
Shares Change (YoY)	+4.49%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	0.99%
Owned by Institutions (%)	51.34%
Float	518.99M

Valuation Ratios

The trailing PE ratio is 48.27 and the forward PE ratio is 15.69.

PE Ratio	48.27
Forward PE	15.69
PS Ratio	0.94
PB Ratio	2.24
P/TBV Ratio	13.17
P/FCF Ratio	5.08
P/OCF Ratio	4.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 7.14.

EV / Earnings	67.81
EV / Sales	1.33
EV / EBITDA	7.99
EV / EBIT	15.66
EV / FCF	7.14

Financial Position

The company has a current ratio of 2.18, with a Debt / Equity ratio of 1.21.

Current Ratio	2.18
Quick Ratio	1.08
Debt / Equity	1.21
Debt / EBITDA	3.03
Debt / FCF	2.73
Interest Coverage	2.30

Financial Efficiency

Return on equity (ROE) is 4.61% and return on invested capital (ROIC) is 5.53%.

Return on Equity (ROE)	4.61%
Return on Assets (ROA)	4.64%
Return on Invested Capital (ROIC)	5.53%
Return on Capital Employed (ROCE)	9.77%
Revenue Per Employee	243,320
Profits Per Employee	4,742
Employee Count	2,348
Asset Turnover	0.87
Inventory Turnover	1.22

Taxes

In the past 12 months, Dr. Martens has paid 12.84 million in taxes.

Income Tax	12.84M
Effective Tax Rate	42.26%

Stock Price Statistics

The stock price has increased by +29.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+29.23%
50-Day Moving Average	0.98
200-Day Moving Average	0.83
Relative Strength Index (RSI)	37.50
Average Volume (20 Days)	164

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Martens had revenue of EUR 900.28 million and earned 17.55 million in profits. Earnings per share was 0.02.

Revenue	900.28M
Gross Profit	589.83M
Operating Income	76.61M
Pretax Income	30.39M
Net Income	17.55M
EBITDA	92.78M
EBIT	76.61M
Earnings Per Share (EPS)	0.02

Balance Sheet

The company has 109.75 million in cash and 455.42 million in debt, giving a net cash position of -345.66 million.

Cash & Cash Equivalents	109.75M
Total Debt	455.42M
Net Cash	-345.66M
Net Cash Per Share	n/a
Equity (Book Value)	377.43M
Book Value Per Share	0.39
Working Capital	246.34M

Cash Flow

In the last 12 months, operating cash flow was 176.39 million and capital expenditures -9.63 million, giving a free cash flow of 166.75 million.

Operating Cash Flow	176.39M
Capital Expenditures	-9.63M
Free Cash Flow	166.75M
FCF Per Share	n/a

Margins

Gross margin is 65.52%, with operating and profit margins of 8.51% and 1.95%.

Gross Margin	65.52%
Operating Margin	8.51%
Pretax Margin	3.38%
Profit Margin	1.95%
EBITDA Margin	10.31%
EBIT Margin	8.51%
FCF Margin	18.52%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.56%.

Dividend Per Share	0.03
Dividend Yield	3.56%
Dividend Growth (YoY)	0.20%
Years of Dividend Growth	n/a
Payout Ratio	115.69%
Buyback Yield	-4.49%
Shareholder Yield	-0.94%
Earnings Yield	2.07%
FCF Yield	19.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Martens has an Altman Z-Score of 4.97 and a Piotroski F-Score of 6.

Altman Z-Score	4.97
Piotroski F-Score	6